OpenVSafe by OpenVAERS
Search V-safe

9KF-33278-69214

5 vaccinations 13 coded responses 30 check-ins 12 free-text entries 4 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
864 / AZ
Registered
2021-01-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-29
    Dose 1 — Moderna
  2. 2021-01-01
    Registered in v-safe
  3. 2021-01-01
    Survey response — days 1–6 daily, dose 1
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Be unable to do your normal daily activities
    Free text: Dizziness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-01-01
    Report sent to call center — days 1–6 daily, dose 1
    Be unable to do your normal daily activities
    1 call case(s)
  5. 2021-01-02
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-01-03
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache
    Adult check-in
  7. 2021-01-04
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-01-06
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-01-13
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  10. 2021-01-19
    Survey response — day 21, dose 1
    MedDRA: Aphasia, Dizziness, Erythema, Headache, Respiratory tract congestion — Feeling: Fair
    Free text: Congestion, headache, little dizziness, slight loss of words, dropping small items and a bit of skin redness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-01-26
    Health check-in — day 28, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-01-27
    Dose 2 — Moderna
  13. 2021-01-28
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Fever · Joint pains, Muscle or body aches
    Adult check-in
  14. 2021-01-29
    Survey response — days 1–6 daily, dose 2
    MedDRA: Axillary pain, Musculoskeletal discomfort, Pain — Feeling: Good · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches
    Free text: Pain and discomfort; bilateral axillas and upper medial arms.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-31
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Swelling · None
    Adult check-in
  16. 2021-02-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Good · Site: Swelling · Nausea
    Free text: Some dizziness.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-02-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness, Eye pain, Pain — Feeling: Fair · Site: Swelling
    Free text: Dizziness and sharp stabbing pain in left eye and finger tips.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-02-04
    Health check-in — day 7, dose 2
    Feeling: Good · Joint pains
    Adult check-in
  19. 2021-02-10
    Survey response — day 14, dose 2
    MedDRA: Arthralgia, Chills, Dizziness, Headache, Hyperhidrosis, Lymphadenopathy, Pain — Feeling: Good
    Free text: On Feb. 6th & 7th I had trouble with dizziness, cold chills, sweating, headaches, sharp shooting joint pain and swollen lymph nodes.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-24
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-03-04
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-10
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-30
    Survey response — 3 months, dose 2
    MedDRA: Arthralgia, Dizziness, Headache — Feeling: Good · Be unable to do your normal daily activities
    Free text: Headaches, Dizziness, and joint pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  24. 2021-07-30
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-11-13
    Dose 3 — Moderna
  26. 2021-12-06
    Dose 4 — Other-Unknown
  27. 2022-01-29
    Survey response — 12 months, dose 2
    MedDRA: Chest discomfort, Dyspnoea, Productive cough, Respiratory tract congestion, Sputum discoloured, Wheezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Chest tightness, shortness of breath, cough with thick yellow mucus, congestion and wheezing.
    MedDRA releases: 2024-11 · check-in free text available
  28. 2022-03-09
    Survey response — 3 months, dose 4
    MedDRA: Blood pressure increased — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: Increased blood pressure.
    MedDRA releases: 2024-11 · check-in free text available
  29. 2022-03-09
    Report sent to call center — 3 months, dose 4
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  30. 2022-03-10
  31. 2022-06-09
    Survey response — 6 months, dose 4
    MedDRA: Cough, Nasopharyngitis — Feeling: Good
    Free text: Upper respiratory cold, cough.
    MedDRA releases: 2024-11 · check-in free text available
  32. 2022-11-09
    Dose 5 — Moderna
    Co-administered: Flu
  33. 2022-12-06
    Survey response — day 21, dose 5
    MedDRA: COVID-19 — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID-19 positive.
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-12-06
    Survey response — 12 months, dose 4
    MedDRA: COVID-19 — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID positive
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-12-06
    Report sent to call center — 12 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  36. 2022-12-06
    Report sent to call center — day 21, dose 5
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2022-12-07
    Call successful
    Not applicable - Accidental Reporting
  38. 2022-12-07
    Call successful
    Not applicable - Accidental Reporting
  39. 2022-12-07
    Call successful
    Not applicable - Accidental Reporting
  40. 2022-12-08
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  41. 2022-12-14
    Health check-in — day 35, dose 5
    Feeling: Good
    Adult check-in
  42. 2022-12-22
    Health check-in — day 42, dose 5
    Feeling: Good
    Adult check-in
  43. 2023-02-08
    Health check-in — 3 months, dose 5
    Feeling: Fair
    Adult check-in
  44. 2023-05-10
    Survey response — 6 months, dose 5
    MedDRA: Pre-existing disease — Feeling: Fair · Be unable to work or attend school
    MedDRA releases: 2024-11

Vaccinations

DoseDateManufacturerCo-administered
12020-12-29Moderna
22021-01-27Moderna
32021-11-13Moderna No
42021-12-06Other-Unknown No
52022-11-09Moderna Flu

Call center

4 call center cases

3 successful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2021-01-01

Systemic reaction (other): Dizziness

Release 2 — day 21, dose 1

2021-01-19

Symptoms: Congestion, headache, little dizziness, slight loss of words, dropping small items and a bit of skin redness.

Release 3 — days 1–6 daily, dose 2

2021-01-29

Systemic reaction (other): Pain and discomfort; bilateral axillas and upper medial arms.

2021-02-01

Systemic reaction (other): Some dizziness.

2021-02-02

Systemic reaction (other): Dizziness and sharp stabbing pain in left eye and finger tips.

Release 4 — day 14, dose 2

2021-02-10

Symptoms: On Feb. 6th & 7th I had trouble with dizziness, cold chills, sweating, headaches, sharp shooting joint pain and swollen lymph nodes.

Release 8 — 3 months, dose 2

2021-04-30

Symptoms: Headaches, Dizziness, and joint pain.

Release 11 — 12 months, dose 2

2022-01-29

Symptoms: Chest tightness, shortness of breath, cough with thick yellow mucus, congestion and wheezing.

Release 11 — 3 months, dose 4

2022-03-09

Symptoms: Increased blood pressure.

Release 12 — 6 months, dose 4

2022-06-09

Symptoms: Upper respiratory cold, cough.

Release 12 — day 21, dose 5

2022-12-06

Symptoms: COVID-19 positive.

Release 12 — 12 months, dose 4

2022-12-06

Symptoms: COVID positive

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAphasia ✓ ✓ ✓
SDArthralgia ✓ ✓ ✓
SDBlood pressure increased · · ✓
SDChest discomfort · · ✓
SDChills ✓ ✓ ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDizziness ✓ ✓ ✓
SDDyspnoea · · ✓
SDErythema ✓ ✓ ✓
SDHeadache ✓ ✓ ✓
SDHyperhidrosis ✓ ✓ ✓
SDLymphadenopathy ✓ ✓ ✓
SDNasopharyngitis · · ✓
SDPain · · ✓
SDPre-existing disease · · ✓
SDProductive cough · · ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDSputum discoloured · · ✓
SDWheezing · · ✓
SROAxillary pain ✓ ✓ ✓
SRODizziness ✓ ✓ ✓
SROEye pain ✓ ✓ ✓
SROMusculoskeletal discomfort ✓ ✓ ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release